resveratrol has been researched along with Injury, Myocardial Reperfusion in 72 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (1.39) | 18.2507 |
2000's | 25 (34.72) | 29.6817 |
2010's | 32 (44.44) | 24.3611 |
2020's | 14 (19.44) | 2.80 |
Authors | Studies |
---|---|
He, J; Li, T; Liu, L; Ouyang, S; Tan, Y | 1 |
Buttari, B; Profumo, E; Retamal, C; Rodrigo, R; Saha, S; Saso, L; Schupper, D; Vergara-Hernández, D | 1 |
Cui, H; Li, Q; Li, X; Yang, Y; Zong, W | 1 |
Gao, F; Li, H; Shi, G; Sun, J; Zhang, Y; Zheng, F | 1 |
Bai, Y; Fu, R; Huang, X; Li, Z; Liu, L; Liu, M; Sun, X; Zheng, M | 1 |
Duan, QJ; Li, J; Shen, J | 1 |
Tian, H; Xia, Z; Xiong, Y | 1 |
Chen, H; Liu, H; Liu, S; Ren, J; Tang, L; Wang, X; Zhao, X; Zhou, T | 1 |
Fu, J; Wang, X; Xu, G; Zhao, X | 1 |
Chen, HP; Deng, YZ; Huang, J; Liu, HY; Ma, ZX; Qiu, LJ; Tang, L; Wang, XY; Xu, XW; Zhou, TT | 1 |
Kazemirad, H; Kazerani, HR | 1 |
Chen, C; Chen, T; He, Y; Lei, W; Lu, X; Yang, Y; Zhang, Y; Zheng, J | 1 |
He, J; Hu, Y; Li, J; Liu, Y; Pan, H; Peng, J; Rong, J; Tang, M; Wang, H; Yan, S; Zheng, Z; Zhong, X | 1 |
C Vedarathinam, R; Ganapathy, A; Kurian, GA; Prem, PN; Rajkumar, Y; Vetriselvan, P | 1 |
Esmaili Dahej, M; Hafizi Barjin, Z; Moradi, A; Safari, F; Soltan, F; Yadegari, M | 1 |
Deng, M; He, S; Wang, D; Xie, Y; Xu, R | 1 |
Bozdogan, O; Eksioglu, D; Erim, F; Firat, T; Kaya, ST; Ozarslan, TO; Taskin, E; Yasar, S | 1 |
Li, BH; Lu, YZ; Meng, DC; Song, J; Wang, D; Wang, J | 1 |
Bernard, M; Desrois, M; Fourny, N; Lan, C; Sérée, E | 1 |
Feng, HK; Hua, L; Huang, LF; Shen, B; Zhang, X | 1 |
Chen, HP; Deng, YZ; Li, XR; Liu, HY; Ma, ZX; Qiu, LJ; Xu, RY; Xu, XW; Zhao, L | 1 |
Han, J; Hanh, TM; Jeong, SH; Kim, HK; Kim, N; Ko, KS; Lee, SR; Noh, SJ; Rhee, BD; Song, IS; Song, S; Suh, H | 1 |
Cao, WJ; Dai, T; Ding, JH; Du, RH; Hu, G; Lu, M | 1 |
Cong, X; Dai, Y; Li, Y; Liu, Y; Lu, N; Zhang, H; Zhao, X | 1 |
Bai, WW; Liu, XQ; Lu, XT; Sun, YY; Wang, B; Wang, YB; Xing, YF; Yang, Q; Zhao, YX | 1 |
Chen, A; Jin, W; Song, X; Wang, X; Wu, X; Zhou, S; Zhu, N | 1 |
Li, H; Li, J; Shao, C; Wang, H; Xie, C; Yao, Y; Zhuang, J | 1 |
He, M; Lai, S; Liao, Z; Liu, D; Tang, L; Yao, J; Yin, D; Yin, S | 1 |
Clemons, TD; Cserne Szappanos, H; Hardy, N; Hool, LC; Iyer, KS; Johnstone, VP; Singh, R; Smith, NM; Viola, HM | 1 |
Fukuda, K; Ishii, I; Ito, K; Katsumata, Y; Matsuhashi, T; Sano, M; Shinmura, K; Suematsu, M; Tamaki, K; Yamamoto, T; Yan, X | 1 |
Guo, H; Hong, Y; Wang, J; Zheng, F; Zheng, H | 1 |
Albiero, M; Avogaro, A; Bova, S; Cattelan, A; Ceolotto, G; de Kreutzenberg, SV; De Martin, S; Fadini, GP; Kuppusamy, M; Semplicini, A | 1 |
Cao, F; Chen, Y; Han, D; Ma, S; Wang, J | 1 |
Netticadan, T; Raj, P; Zieroth, S | 1 |
Ding, J; Dong, W; Wu, H; Yang, J; Yang, R; Zhang, J | 1 |
Anzai, A; Endo, J; Fukuda, K; Inaba, T; Ito, K; Katsumata, Y; Matsuhashi, T; Sano, M; Shinmura, K; Shirakawa, K; Tamaki, K; Tsubota, K; Yamamoto, T; Yan, X | 1 |
Gao, C; Liu, Y; Sun, L; Tao, L; Wang, HC; Yang, Q | 1 |
Kang, L; Li, J; Liu, F; Liu, J; Qi, Z; Shen, Y; Wang, X; Wang, Y; Yang, L; Yang, Y; Zhang, J; Zhang, Q; Zhang, Y; Zhu, M | 1 |
Ananthakrishnan, R; Caspersen, C; Gomez, T; Hwang, YC; Kaneko, M; Li, Q; Quadri, N; Ramasamy, R | 1 |
Mueller, RA; Norfleet, EA; Wang, H; Xi, J; Xu, Z | 1 |
Chen, WP; Hsueh, CH; Hung, LM; Lai, LP; Su, MJ | 1 |
Chang, CC; Day, YJ; Deng, JY; Huang, JP; Huang, SS; Hung, LM | 1 |
Borriello, A; Cucciolla, V; Della Ragione, F; Galletti, P | 1 |
Das, DK; Gesztelyi, R; Juhasz, A; Juhasz, B; Juhaz, B; Kertesz, A; Varga, B | 1 |
Mustafi, M; Usta, E; Walker, T; Ziemer, G | 1 |
Adachi, T; Amo, T; Fukuda, K; Ishiwata, K; Katsumata, Y; Nakashima-Kamimura, N; Ohta, S; Sano, M; Shinmura, K; Suematsu, M; Tamaki, K; Wolf, AM | 1 |
Fukui, A; Kume, O; Nakagawa, M; Nishio, S; Saikawa, T; Saito, S; Takahashi, N; Teshima, Y; Thuc, LC | 1 |
Camara, AK; Gadicherla, AK; Kwok, WM; Stowe, DF; Wakim, BT; Yang, M; Zhou, Y | 1 |
He, D; Liu, L; Liu, X; Pang, Y | 1 |
Barenghi, L; Beemster, P; Bertelli, AA; Bradamante, S; De Jong, JW; De Jonge, R; Piccinini, F | 1 |
Eigel, BN; Gursahani, H; Hadley, RW | 1 |
Chen, LN; Tang, YH; Zang, WJ | 1 |
Chen, JK; Hung, LM; Su, MJ | 1 |
Barenghi, L; Bradamante, S; Villa, A | 1 |
Dernek, S; Ergun, B; Erkasap, N; Ikizler, M; Kaygisiz, Z; Koken, T; Kural, T; Sevin, B; Yilmaz, K | 1 |
Cingolani, HE; Fantinelli, JC; Mosca, SM; Schinella, G | 1 |
Chen, JK; Chow, SE | 1 |
Jia, GL; Ma, H; Shen, M; Wang, YM | 1 |
Das, DK; Das, S; Fraga, CG | 1 |
Chen, WP; Hung, LM; Su, MJ | 1 |
Amri, M; Aouani, E; Elkahoui, S; Limam, F; Mokni, M | 1 |
Bertelli, A; Das, DK; Das, S; Falchi, M; Maulik, N | 1 |
Huo, R; Lin, DH; Lü, YJ; Wang, N; Wang, Y; Xiao, J; Yang, BF; Yue, P; Zhang, Y | 1 |
Bagchi, D; Das, DK; Das, S; Gurusamy, N; Khan, N; Mukherjee, S; Swartz, H | 1 |
Bak, I; Das, DK; Das, M; Das, S; Gesztelyi, R; Juhasz, B; Lekli, I; Szabo, G; Szendrei, L; Tosaki, A; Varadi, J; Varga, E | 1 |
Sack, MN; Schwartz, DR | 1 |
Bertelli, A; Bertelli, AA; Cordis, GA; Das, DK; Maulik, G; Ray, PS | 1 |
Chen, JK; Huang, SS; Hung, LM; Lee, RS; Su, MJ | 1 |
Chen, JK; Hung, LM; Lee, RS; Liang, HC; Su, MJ | 1 |
Hale, SL; Kloner, RA | 1 |
Das, DK; Hattori, R; Maulik, N; Otani, H | 1 |
Bertelli, A; Bertelli, AA; Das, DK; Imamura, G; Maulik, N; Otani, H | 1 |
8 review(s) available for resveratrol and Injury, Myocardial Reperfusion
Article | Year |
---|---|
Antioxidant Cardioprotection against Reperfusion Injury: Potential Therapeutic Roles of Resveratrol and Quercetin.
Topics: Antioxidants; Humans; Myocardial Infarction; Myocardial Reperfusion Injury; Percutaneous Coronary Intervention; Quercetin; Reperfusion Injury; Resveratrol | 2022 |
SIRT1 as a Promising Novel Therapeutic Target for Myocardial Ischemia Reperfusion Injury and Cardiometabolic Disease.
Topics: Animals; Apoptosis; Disease Models, Animal; Heterocyclic Compounds, 4 or More Rings; Humans; Metabolic Diseases; Molecular Targeted Therapy; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocytes, Cardiac; Resveratrol; Sirtuin 1; Stilbenes; Transcriptional Activation | 2017 |
An overview of the efficacy of resveratrol in the management of ischemic heart disease.
Topics: Animals; Cardiotonic Agents; Coronary Artery Disease; Genetic Therapy; Humans; Myocardial Reperfusion Injury; Resveratrol; Stilbenes | 2015 |
Dietary polyphenols: focus on resveratrol, a promising agent in the prevention of cardiovascular diseases and control of glucose homeostasis.
Topics: Animals; Anti-Inflammatory Agents; Cardiovascular Diseases; Cholesterol; Glucose; Homeostasis; Humans; Macrophages; Myocardial Reperfusion Injury; Platelet Aggregation; Resveratrol; Stilbenes | 2010 |
[Progress in cardiovascular protective effects of resveratrol].
Topics: Animals; Antioxidants; Arteriosclerosis; Cardiovascular Agents; Humans; Myocardial Reperfusion Injury; Platelet Aggregation Inhibitors; Resveratrol; Stilbenes; Vasodilator Agents | 2003 |
Cardiovascular protective effects of resveratrol.
Topics: Animals; Antioxidants; Cardiotonic Agents; Cardiovascular Diseases; Cholesterol; Dose-Response Relationship, Drug; Humans; Lipid Peroxidation; Myocardial Reperfusion Injury; Platelet Aggregation Inhibitors; Resveratrol; Stilbenes; Time Factors | 2004 |
Antioxidants and myocardial ischemia: reperfusion injuries.
Topics: Animals; Antioxidants; Calcium; Endothelium, Vascular; Humans; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Reactive Oxygen Species; Resveratrol; Stilbenes | 2005 |
Targeting the mitochondria to augment myocardial protection.
Topics: AMP-Activated Protein Kinases; Animals; Antioxidants; Drug Delivery Systems; Homeostasis; Humans; Ischemic Preconditioning; Mitochondria; Multienzyme Complexes; Myocardial Reperfusion Injury; Nitrites; Organophosphorus Compounds; Protein Serine-Threonine Kinases; Resveratrol; Stilbenes; Ubiquinone | 2008 |
64 other study(ies) available for resveratrol and Injury, Myocardial Reperfusion
Article | Year |
---|---|
Resveratrol protects against myocardial ischemia-reperfusion injury via attenuating ferroptosis.
Topics: Animals; Apoptosis; Autophagy; Cell Line; Cell Survival; Ferroptosis; Glucose; Heart; Male; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; Oxidative Stress; Oxygen; Protective Agents; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Resveratrol; Signal Transduction | 2022 |
Resveratrol regulates paracrine function of cardiac microvascular endothelial cells under hypoxia/reoxygenation condition.
Topics: Apoptosis; Cells, Cultured; Endothelial Cells; Humans; Hypoxia; Myocardial Reperfusion Injury; Resveratrol | 2022 |
Resveratrol, novel application by preconditioning to attenuate myocardial ischemia/reperfusion injury in mice through regulate AMPK pathway and autophagy level.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Autophagy; Mice; Myocardial Reperfusion Injury; Myocytes, Cardiac; Rats; Resveratrol; Signal Transduction; Sirtuin 1 | 2022 |
Resveratrol Reestablishes Mitochondrial Quality Control in Myocardial Ischemia/Reperfusion Injury through Sirt1/Sirt3-Mfn2-Parkin-PGC-1α Pathway.
Topics: Animals; Mitochondria, Heart; Myocardial Reperfusion Injury; Myocytes, Cardiac; Rats; Resveratrol; Sirtuin 1; Sirtuin 3; Sirtuins; Ubiquitin-Protein Ligases | 2022 |
[Resveratrol pretreatment improves mitochondrial function and alleviates myocardial ischemia-reperfusion injury by up-regulating mi R-20b-5p to inhibit STIM2].
Topics: Adenosine Triphosphate; Animals; Antagomirs; bcl-2-Associated X Protein; Caspase 3; Glucose; MicroRNAs; Mitochondria, Heart; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Oxygen; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; Stromal Interaction Molecule 2 | 2022 |
Resveratrol ameliorates myocardial ischemia/reperfusion induced necroptosis through inhibition of the Hippo pathway.
Topics: Animals; Apoptosis; Hippo Signaling Pathway; Myocardial Reperfusion Injury; Myocytes, Cardiac; Necroptosis; Rats; Rats, Sprague-Dawley; Resveratrol | 2023 |
Resveratrol inhibits autophagy against myocardial ischemia-reperfusion injury through the DJ-1/MEKK1/JNK pathway.
Topics: Animals; Apoptosis; Autophagy; MAP Kinase Kinase Kinases; MAP Kinase Signaling System; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocytes, Cardiac; Rats; Resveratrol | 2023 |
Resveratrol increase myocardial Nrf2 expression in type 2 diabetic rats and alleviate myocardial ischemia/reperfusion injury (MIRI).
Topics: Animals; Antioxidants; Diabetes Mellitus, Type 2; Disease Models, Animal; Heart; Myocardial Reperfusion Injury; Myocardium; NF-E2-Related Factor 2; Rats; Resveratrol; Up-Regulation | 2019 |
Mitochondrial Translocation of DJ-1 Is Mediated by Grp75: Implication in Cardioprotection of Resveratrol Against Hypoxia/Reoxygenation-Induced Oxidative Stress.
Topics: Animals; Antioxidants; Cell Hypoxia; Cell Line; Electron Transport Complex IV; HSP70 Heat-Shock Proteins; Mitochondria, Heart; Mitochondrial Proteins; Myocardial Reperfusion Injury; Myocytes, Cardiac; NADH Dehydrogenase; Oxidative Stress; Protein Deglycase DJ-1; Protein Transport; Rats; Resveratrol; RNA Interference; RNA, Small Interfering | 2020 |
Cardioprotective effects of resveratrol following myocardial ischemia and reperfusion.
Topics: Animals; Antioxidants; Cardiotonic Agents; Disease Models, Animal; Heart; Hemodynamics; Male; Myocardial Reperfusion Injury; Oxidative Stress; Rats; Rats, Wistar; Resveratrol | 2020 |
Resveratrol protects against myocardial ischemic injury via the inhibition of NF‑κB‑dependent inflammation and the enhancement of antioxidant defenses.
Topics: Animals; Antioxidants; Cell Line; Inflammation; Male; Mice; Myocardial Reperfusion Injury; NF-kappa B; Rats; Resveratrol | 2021 |
Resveratrol inhibits necroptosis by mediating the TNF-α/RIP1/RIP3/MLKL pathway in myocardial hypoxia/reoxygenation injury.
Topics: Animals; Male; Myocardial Reperfusion Injury; Necroptosis; Protein Kinases; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; Receptor-Interacting Protein Serine-Threonine Kinases; Resveratrol; Signal Transduction; Tumor Necrosis Factor-alpha | 2021 |
Resveratrol-mediated cardioprotection against myocardial ischemia-reperfusion injury was revoked by statin-induced mitochondrial alterations.
Topics: Animals; Heart; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Wistar; Resveratrol | 2022 |
Resveratrol Confers Protection Against Ischemia/Reperfusion Injury by Increase of Angiotensin (1-7) Expression in a Rat Model of Myocardial Hypertrophy.
Topics: Angiotensin I; Animals; Disease Models, Animal; Hypertrophy, Left Ventricular; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Peptide Fragments; Proto-Oncogene Mas; Rats, Wistar; Resveratrol; Tachycardia, Ventricular; Ventricular Fibrillation | 2021 |
SIRT1 confers protection against ischemia/reperfusion injury in cardiomyocytes via regulation of uncoupling protein 2 expression.
Topics: Animals; Cell Hypoxia; Cell Line; Cell Survival; Down-Regulation; Male; Mice; Mice, Inbred C57BL; Myocardial Reperfusion Injury; Myocytes, Cardiac; Rats; Resveratrol; RNA Interference; RNA, Messenger; RNA, Small Interfering; Sirtuin 1; Stilbenes; Uncoupling Protein 2 | 2017 |
The protection of resveratrol and its combination with glibenclamide, but not berberine on the diabetic hearts against reperfusion-induced arrhythmias: the role of myocardial K
Topics: Animals; Arrhythmias, Cardiac; Berberine; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Drug Interactions; Glyburide; Heart; Hemodynamics; Male; Myocardial Reperfusion Injury; Potassium Channels, Inwardly Rectifying; Rats; Rats, Sprague-Dawley; Resveratrol | 2019 |
[A study on anti-arrhythmia mechanisms of resveratrol on ischemia/reperfusion in rats by regulating PI3K/Akt signaling pathway].
Topics: Animals; Arrhythmias, Cardiac; Chromones; Male; Morpholines; Myocardial Reperfusion Injury; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Resveratrol; Signal Transduction; Stilbenes; Ventricular Function, Left | 2017 |
Protective Effect of Resveratrol against Ischemia-Reperfusion Injury via Enhanced High Energy Compounds and eNOS-SIRT1 Expression in Type 2 Diabetic Female Rat Heart.
Topics: Adenosine Triphosphate; Animals; Cardiotonic Agents; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Energy Metabolism; Female; Gene Expression; Magnetic Resonance Spectroscopy; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphocreatine; Rats; Rats, Wistar; Resveratrol; Sirtuin 1 | 2019 |
Resveratrol protects myocardial apoptosis induced by ischemia-reperfusion in rats with acute myocardial infarction via blocking P13K/Akt/e-NOS pathway.
Topics: Acute Disease; Animals; Apoptosis; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinases; Protective Agents; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Resveratrol | 2019 |
Resveratrol attenuates myocardial hypoxia/reoxygenation-induced cell apoptosis through DJ-1-mediated SIRT1-p53 pathway.
Topics: Acetylation; Animals; Apoptosis; Cardiotonic Agents; Cell Hypoxia; Cell Line; Cell Survival; Enzyme Activation; L-Lactate Dehydrogenase; Myocardial Ischemia; Myocardial Reperfusion Injury; Protein Binding; Protein Deglycase DJ-1; Rats; Resveratrol; Sirtuin 1; Tumor Suppressor Protein p53 | 2019 |
HS-1793, a recently developed resveratrol analogue protects rat heart against hypoxia/reoxygenation injury via attenuating mitochondrial damage.
Topics: Animals; Calcium; Heart; Hypoxia; Mitochondria; Myocardial Reperfusion Injury; Naphthols; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resorcinols; Resveratrol; Stilbenes | 2013 |
Kir6.2-containing ATP-sensitive K(+) channel is required for cardioprotection of resveratrol in mice.
Topics: Animals; Cardiotonic Agents; Cells, Cultured; KATP Channels; Male; Mice; Mice, Knockout; Myocardial Reperfusion Injury; Myocytes, Cardiac; Potassium Channels, Inwardly Rectifying; Resveratrol; Stilbenes | 2014 |
Resveratrol attenuates the inflammatory reaction induced by ischemia/reperfusion in the rat heart.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Creatine Kinase; Disease Models, Animal; Inflammation; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Neutrophil Infiltration; Rats; Resveratrol; Stilbenes; Tumor Necrosis Factor-alpha | 2014 |
Resveratrol-enhanced autophagic flux ameliorates myocardial oxidative stress injury in diabetic mice.
Topics: Acetylation; Animals; Antioxidants; Apoptosis; Autophagy; Blotting, Western; Cells, Cultured; Diabetes Mellitus, Experimental; Immunoenzyme Techniques; Male; Mice; Mice, Inbred C57BL; Myocardial Reperfusion Injury; Oxidation-Reduction; Oxidative Stress; rab GTP-Binding Proteins; rab7 GTP-Binding Proteins; Real-Time Polymerase Chain Reaction; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Sirtuin 1; Stilbenes | 2014 |
Resveratrol attenuates hypoxia/reoxygenation‑induced Ca2+ overload by inhibiting the Wnt5a/Frizzled‑2 pathway in rat H9c2 cells.
Topics: Animals; Apoptosis; Calcium; Cardiotonic Agents; Cell Hypoxia; Cell Line; Drug Evaluation, Preclinical; Frizzled Receptors; Gene Expression; Myocardial Reperfusion Injury; Rats; Resveratrol; Stilbenes; Wnt Proteins; Wnt Signaling Pathway; Wnt-5a Protein | 2014 |
Resveratrol attenuates inflammation in the rat heart subjected to ischemia-reperfusion: Role of the TLR4/NF-κB signaling pathway.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Disease Models, Animal; Down-Regulation; Heart; Inflammation; Male; Myocardial Reperfusion Injury; Myocardium; Neutrophils; NF-kappa B; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peroxidase; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Stilbenes; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2015 |
Long-term oral resveratrol intake provides nutritional preconditioning against myocardial ischemia/reperfusion injury: involvement of VDAC1 downregulation.
Topics: Administration, Oral; Animals; Apoptosis; Cardiotonic Agents; Caspase 3; Cytochromes c; Down-Regulation; Gene Expression Regulation; Heart; Ischemic Preconditioning, Myocardial; Mice; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Reperfusion Injury; Organ Culture Techniques; Resveratrol; Stilbenes; Voltage-Dependent Anion Channel 1 | 2015 |
Nanoparticle-mediated dual delivery of an antioxidant and a peptide against the L-Type Ca2+ channel enables simultaneous reduction of cardiac ischemia-reperfusion injury.
Topics: Animals; Antioxidants; Calcium Channels, L-Type; Curcumin; Drug Carriers; Drug Interactions; Male; Membrane Potential, Mitochondrial; Mice; Myocardial Reperfusion Injury; Myocytes, Cardiac; Nanoparticles; Oxidative Stress; Peptide Fragments; Polyethyleneimine; Polymethacrylic Acids; Rats; Resveratrol; Stilbenes; Superoxides | 2015 |
Indispensable role of endothelial nitric oxide synthase in caloric restriction-induced cardioprotection against ischemia-reperfusion injury.
Topics: Animals; Caloric Restriction; Hydralazine; Mice; Mice, Inbred C57BL; Myocardial Reperfusion Injury; Nitric Oxide Synthase Type III; Resveratrol; Sirtuin 1; Stilbenes; Vasodilator Agents | 2015 |
The effects of age and resveratrol on the hypoxic preconditioning protection against hypoxia-reperfusion injury: studies in rat hearts and human cardiomyocytes.
Topics: Age Factors; Animals; Cardiotonic Agents; Cells, Cultured; Heart Rate; Humans; Ischemic Preconditioning, Myocardial; Male; Myocardial Reperfusion Injury; Myocytes, Cardiac; Rats; Resveratrol; Stilbenes; Ventricular Function | 2015 |
NAD(+)-dependent SIRT1 deactivation has a key role on ischemia-reperfusion-induced apoptosis.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Binding Sites; Caspase 3; DNA-Binding Proteins; Enzyme Activation; Forkhead Transcription Factors; Glucose; Heat Shock Transcription Factors; Isolated Heart Preparation; Male; Myocardial Reperfusion Injury; Myocytes, Cardiac; NAD; Nerve Tissue Proteins; Promoter Regions, Genetic; Rats, Inbred WKY; Resveratrol; Signal Transduction; Sirtuin 1; Sirtuins; Stilbenes; Time Factors; Transcription Factors | 2015 |
Resveratrol pretreatment protects rat hearts from ischemia/reperfusion injury partly via a NALP3 inflammasome pathway.
Topics: Animals; Antioxidants; Blotting, Western; Carrier Proteins; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Heart; Inflammasomes; Male; Microscopy, Electron, Transmission; Myocardial Reperfusion Injury; Myocardium; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Rats, Sprague-Dawley; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stilbenes | 2015 |
Cardiac Sirt1 mediates the cardioprotective effect of caloric restriction by suppressing local complement system activation after ischemia-reperfusion.
Topics: Animals; Antioxidants; Caloric Restriction; Cells, Cultured; Complement Activation; Complement C3; Disease Models, Animal; Genotype; Isolated Heart Preparation; Mice, Inbred C57BL; Mice, Knockout; Myocardial Reperfusion Injury; Myocytes, Cardiac; Nitric Oxide Synthase Type III; Oxidative Stress; Phenotype; Phosphorylation; Rats, Sprague-Dawley; Resveratrol; Sirtuin 1; Stilbenes; Time Factors; Ventricular Function, Left | 2016 |
Resveratrol Cardioprotection Against Myocardial Ischemia/Reperfusion Injury Involves Upregulation of Adiponectin Levels and Multimerization in Type 2 Diabetic Mice.
Topics: Adiponectin; Animals; Cardiotonic Agents; Diabetes Mellitus, Type 2; Male; Mice; Mice, Inbred C57BL; Myocardial Reperfusion Injury; Protein Multimerization; Random Allocation; Resveratrol; Stilbenes; Up-Regulation | 2016 |
Resveratrol attenuates myocardial ischemia/reperfusion injury through up-regulation of vascular endothelial growth factor B.
Topics: Animals; Antioxidants; Apoptosis; Cardiotonic Agents; Cell Line; Creatine Kinase, MB Form; Gene Expression Regulation; Glycogen Synthase Kinase 3 beta; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; Organ Culture Techniques; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; RNA, Small Interfering; Signal Transduction; Stilbenes; Superoxide Dismutase; Vascular Endothelial Growth Factor B; Ventricular Function, Left | 2016 |
Aldose reductase mediates myocardial ischemia-reperfusion injury in part by opening mitochondrial permeability transition pore.
Topics: Aldehyde Reductase; Animals; Antioxidants; Calcium; Cyclosporine; Deoxyglucose; Disease Models, Animal; Glutathione; Humans; Hydrogen Peroxide; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Mitochondrial Swelling; Myocardial Reperfusion Injury; Myocardium; Reactive Oxygen Species; Resveratrol; Stilbenes | 2009 |
Mechanism for resveratrol-induced cardioprotection against reperfusion injury involves glycogen synthase kinase 3beta and mitochondrial permeability transition pore.
Topics: Animals; Blotting, Western; Cardiotonic Agents; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Immunoprecipitation; In Vitro Techniques; Male; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Mitochondrial Swelling; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2009 |
Piceatannol, a derivative of resveratrol, moderately slows I(Na) inactivation and exerts antiarrhythmic action in ischaemia-reperfused rat hearts.
Topics: Aconitine; Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Caffeine; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Electric Stimulation; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Free Radical Scavengers; Humans; In Vitro Techniques; Male; Myocardial Reperfusion Injury; Myocytes, Cardiac; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Resveratrol; Sodium Channel Agonists; Sodium Channel Blockers; Sodium Channels; Stilbenes | 2009 |
Insulin and resveratrol act synergistically, preventing cardiac dysfunction in diabetes, but the advantage of resveratrol in diabetics with acute heart attack is antagonized by insulin.
Topics: Acute Disease; Animals; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Drug Antagonism; Drug Evaluation, Preclinical; Drug Synergism; Heart Failure; Hemodynamics; Hypoglycemic Agents; Insulin; Male; Myocardial Reperfusion Injury; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Streptozocin; Vasodilator Agents | 2010 |
Reduction of blood cholesterol and ischemic injury in the hypercholesteromic rabbits with modified resveratrol, longevinex. [corrected]
Topics: Animals; Anticholesteremic Agents; Arteriosclerosis; Biomarkers; Cholesterol; Disease Models, Animal; Down-Regulation; Hemodynamics; Hypercholesterolemia; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Rabbits; Resveratrol; Stilbenes; Time Factors; Ventricular Function, Left; Ventricular Pressure | 2011 |
Resveratrol suppresses apoptosis in intact human cardiac tissue - in vitro model simulating extracorporeal circulation.
Topics: Aged; Apoptosis; Biopsy; Caspase 3; Cytokines; Extracorporeal Circulation; Female; Gene Expression Regulation; Heart Arrest, Induced; Humans; Immunohistochemistry; In Vitro Techniques; Male; Middle Aged; Myocardial Reperfusion Injury; Myocytes, Cardiac; Perfusion; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Protective Agents; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Stilbenes; Time Factors | 2011 |
Caloric restriction primes mitochondria for ischemic stress by deacetylating specific mitochondrial proteins of the electron transport chain.
Topics: Acetylation; Animals; Antioxidants; Blotting, Western; Caloric Restriction; Cells, Cultured; Disease Models, Animal; Electron Transport Chain Complex Proteins; Electron Transport Complex III; Humans; Hydrogen Peroxide; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Reperfusion Injury; Myocytes, Cardiac; NAD; NADH Dehydrogenase; Niacinamide; Oxidative Stress; Proteomics; Rats; Rats, Inbred F344; Resveratrol; Sirtuins; Stilbenes | 2011 |
Inhibition of Na⁺-H⁺ exchange as a mechanism of rapid cardioprotection by resveratrol.
Topics: Animals; Calcium; Cardiotonic Agents; Cells, Cultured; Heart Ventricles; Hydrogen Peroxide; In Vitro Techniques; Membrane Potential, Mitochondrial; Myocardial Reperfusion Injury; Myocytes, Cardiac; Protein Kinase C; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; Sodium; Sodium-Hydrogen Exchangers; Stilbenes; Ventricular Function | 2012 |
Tyrosine nitration of voltage-dependent anion channels in cardiac ischemia-reperfusion: reduction by peroxynitrite scavenging.
Topics: Animals; Guinea Pigs; Mass Spectrometry; Mitochondrial Proteins; Myocardial Reperfusion Injury; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peroxynitrous Acid; Resveratrol; Stilbenes; Superoxides; Tyrosine; Voltage-Dependent Anion Channels | 2012 |
[Inhibitory effect of resveratrol on ischemia reperfusion-induced cardiocyte apoptosis and its relationship with PI3K-Akt signaling pathway].
Topics: Animals; Apoptosis; Down-Regulation; Humans; Male; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Stilbenes | 2012 |
Resveratrol provides late-phase cardioprotection by means of a nitric oxide- and adenosine-mediated mechanism.
Topics: Adenosine; Animals; Cardiotonic Agents; Coronary Circulation; Enzyme Inhibitors; Heart; In Vitro Techniques; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Theophylline; Time Factors; Vasodilator Agents | 2003 |
ROS are required for rapid reactivation of Na+/Ca2+ exchanger in hypoxic reoxygenated guinea pig ventricular myocytes.
Topics: Animals; Antioxidants; Cells, Cultured; Chromans; Diazoxide; Free Radical Scavengers; Guinea Pigs; Heart Ventricles; Hypoxia; Metalloporphyrins; Myocardial Reperfusion Injury; Myocytes, Cardiac; Oxidative Stress; Reactive Oxygen Species; Resveratrol; Sodium-Calcium Exchanger; Stilbenes | 2004 |
Resveratrol protects myocardial ischemia-reperfusion injury through both NO-dependent and NO-independent mechanisms.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Coronary Disease; Creatine Kinase; Gene Expression; Heart Rate; L-Lactate Dehydrogenase; Models, Animal; Myocardial Infarction; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Resveratrol; RNA, Messenger; Stilbenes | 2004 |
Cardioprotection with resveratrol pretreatment: improved beneficial effects over standard treatment in rat hearts after global ischemia.
Topics: Analysis of Variance; Animals; Coronary Circulation; Disease Models, Animal; Hemodynamics; Ischemic Preconditioning, Myocardial; Male; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; Probability; Random Allocation; Rats; Rats, Sprague-Dawley; Resveratrol; Sensitivity and Specificity; Stilbenes; Survival Rate | 2004 |
Effects of different fractions of a red wine non-alcoholic extract on ischemia-reperfusion injury.
Topics: Animals; Argentina; Blood Pressure; Cardiotonic Agents; Flavonols; L-Lactate Dehydrogenase; Lipid Peroxidation; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Phenols; Rats; Rats, Wistar; Resveratrol; Stilbenes; Thiobarbituric Acid Reactive Substances; Ventricular Function, Left; Wine | 2005 |
Cardioprotective effect of resvaratrol pretreatment on myocardial ischemia-reperfusion induced injury in rats.
Topics: Animals; Antioxidants; Cardiotonic Agents; Free Radical Scavengers; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Nitric Oxide; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Up-Regulation | 2006 |
Cardioprotective effect of resveratrol via HO-1 expression involves p38 map kinase and PI-3-kinase signaling, but does not involve NFkappaB.
Topics: Animals; Apoptosis; Cardiotonic Agents; Heart; Heme Oxygenase-1; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Male; Metalloporphyrins; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Kinase Inhibitors; Protoporphyrins; Rats; Resveratrol; Signal Transduction; Stilbenes | 2006 |
In vitro electrophysiological mechanisms for antiarrhythmic efficacy of resveratrol, a red wine antioxidant.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Antioxidants; Arrhythmias, Cardiac; Calcium; Calcium Channels, L-Type; Cells, Cultured; Dose-Response Relationship, Drug; Electrophysiology; Heart Conduction System; In Vitro Techniques; Male; Membrane Potentials; Myocardial Reperfusion Injury; Myocytes, Cardiac; Potassium Channels; Rats; Rats, Sprague-Dawley; Resveratrol; Sodium Channels; Stilbenes; Treatment Outcome; Wine | 2007 |
Strong cardioprotective effect of resveratrol, a red wine polyphenol, on isolated rat hearts after ischemia/reperfusion injury.
Topics: Animals; Cardiotonic Agents; Heart Rate; In Vitro Techniques; Male; Malondialdehyde; Myocardial Contraction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Phenols; Rats; Rats, Wistar; Resveratrol; Stilbenes; Wine | 2007 |
Attenuation of ischemia/reperfusion injury in rats by the anti-inflammatory action of resveratrol.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Blood Pressure; Cell Adhesion Molecules; Enzyme Induction; Heart Function Tests; In Situ Nick-End Labeling; Male; Malondialdehyde; Myocardial Infarction; Myocardial Reperfusion Injury; Nitric Oxide; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Resveratrol; RNA, Messenger; Stilbenes | 2006 |
[Resveratrol restored the structural and functional association between M3 receptor and connexin 43 gap junction proteins in ischemia-reperfusion injury of isolated rat heart].
Topics: Animals; Connexin 43; Electrocardiography; Heart; In Vitro Techniques; Male; Malondialdehyde; Myocardial Reperfusion Injury; Myocardium; Phosphorylation; Protective Agents; Random Allocation; Rats; Rats, Wistar; Receptor, Muscarinic M3; Resveratrol; Stilbenes; Superoxide Dismutase | 2007 |
Redox regulation of resveratrol-mediated switching of death signal into survival signal.
Topics: Animals; Cardiotonic Agents; Cell Death; Cell Survival; Cisplatin; Drug Antagonism; Genes, bcl-2; Male; Mice; Mice, Transgenic; Myocardial Reperfusion Injury; Myocytes, Cardiac; NADH, NADPH Oxidoreductases; Organ Specificity; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Resveratrol; RNA, Antisense; Signal Transduction; Stilbenes; Thioredoxins | 2008 |
Protective mechanisms of resveratrol against ischemia-reperfusion-induced damage in hearts obtained from Zucker obese rats: the role of GLUT-4 and endothelin.
Topics: Animals; Antioxidants; Apoptosis; Blood Glucose; Blood Pressure; Electrocardiography; Endothelin-1; Glucose Transporter Type 4; Heart Rate; In Situ Nick-End Labeling; In Vitro Techniques; Insulin; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Obesity; Rats; Rats, Zucker; Resveratrol; Signal Transduction; Stilbenes | 2008 |
The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury.
Topics: Animals; Antioxidants; Free Radicals; Heart; In Vitro Techniques; Male; Malondialdehyde; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Peroxides; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Wine | 1999 |
Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes.
Topics: Analysis of Variance; Animals; Antioxidants; Blood Pressure; Chi-Square Distribution; Free Radical Scavengers; Heart Rate; L-Lactate Dehydrogenase; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Nitric Oxide; Rats; Rats, Sprague-Dawley; Resveratrol; Statistics, Nonparametric; Stilbenes; Tachycardia, Ventricular; Ventricular Fibrillation | 2000 |
Beneficial effects of astringinin, a resveratrol analogue, on the ischemia and reperfusion damage in rat heart.
Topics: Animals; Antioxidants; Free Radical Scavengers; Heart; Hemodynamics; L-Lactate Dehydrogenase; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Nitrates; Nitric Oxide; Nitrites; Rats; Resveratrol; Stilbenes; Tachycardia, Ventricular; Ventricular Fibrillation | 2001 |
Effects of resveratrol, a flavinoid found in red wine, on infarct size in an experimental model of ischemia/reperfusion.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Blood Pressure; Body Weight; Flavonoids; Heart Rate; Heart Ventricles; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Rabbits; Regional Blood Flow; Resveratrol; Risk Factors; Stilbenes; Wine | 2001 |
Pharmacological preconditioning with resveratrol: role of nitric oxide.
Topics: Animals; Apoptosis; Enzyme Inhibitors; Gene Expression; Guanidines; Heart Ventricles; Ischemic Preconditioning; Malondialdehyde; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Resveratrol; RNA, Messenger; Stilbenes | 2002 |
Pharmacological preconditioning with resveratrol: an insight with iNOS knockout mice.
Topics: Animals; Apoptosis; Enzyme Inhibitors; Gene Expression; Guanidines; Heart; Ischemic Preconditioning; Kinetics; Male; Malondialdehyde; Mice; Mice, Knockout; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxidative Stress; Resveratrol; RNA, Messenger; Stilbenes | 2002 |